E. Raymond

Hepatology · 2002–2015

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom E. Raymond trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Llovet
  2. Jordi Bruix1 , 2

Who trusts E. Raymond overall

  1. N. Vasudev
  2. Young Chul Kim

Papers from E. Raymond's perspective

Ordered by how strongly the researchers E. Raymond trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
  2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. (New England Journal of Medicine)
  3. TOR, a central controller of cell growth. (Cell)
  4. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. (Journal of Clinical Oncology)
  5. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
  6. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. (Cell)
  7. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial (Annals of Surgery)
  8. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  9. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
  10. Inhibition of Macroautophagy Triggers Apoptosis (Molecular and Cellular Biology)

Their papers